Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole
J Liu, J Shentu, L Wu, J Dou, Q Xu, H Zhou… - Journal of Zhejiang …, 2012 - Springer
In order to comply with the requirements for a drug listed in China, the study was developed
to compare the pharmacokinetics and relative bioavailability of two different enteric …
to compare the pharmacokinetics and relative bioavailability of two different enteric …
Development of a New Bioequivalent Omeprazole Product
G Kumisbek, D Vetchý, A Kadyrbay - Medicina, 2024 - mdpi.com
Background and Objectives: The enteric form of omeprazole is one of the most commonly
prescribed medications. Similarly to Europe, Kazakhstan relies on the localization of …
prescribed medications. Similarly to Europe, Kazakhstan relies on the localization of …
Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects …
Objective Omeprazole 20 mg enteric coated capsule formulation is generally prepared
either with omeprazole 8.5% or omeprazole 7.5% enteric coated pellets to accommodate in …
either with omeprazole 8.5% or omeprazole 7.5% enteric coated pellets to accommodate in …